Patents by Inventor Ligong Chen

Ligong Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR TREATING CANCER AND USE AND MEDICAMENT THEREOF
    Publication number: 20220305072
    Abstract: The present invention relates to the field of medical technology, in particular to a composition for treating cancer and use and medicament thereof. The composition comprises an SGLT1 inhibitor and a VEGFR2 inhibitor. The present invention finds that SGLT1 interacts with VEGFR2 to promote the development and progression of tumors; the present invention also finds that a composition of a VEGFR2 targeting inhibitor and an SGLT1 inhibitor has a synergistic anti-tumor effect, and the composition of the VEGFR2 targeting inhibitor and the SGLT1 targeting inhibitor can be used in cancer treatment.
    Type: Application
    Filed: August 19, 2020
    Publication date: September 29, 2022
    Applicant: NEWISH TECHNOLOGY (BEIJING) CO., LTD.
    Inventors: Zhongjie SUN, Hailong QI, Ligong CHEN, Huangfan XIE, Defang LIU, Xiaoe E. YAN, Weiwei LI, Xiaofang WANG
  • USE OF MEMORY LYMPHOCYTE POPULATION IN LIVER CANCER TREATMENT
    Publication number: 20210238549
    Abstract: Provided are a memory lymphocyte population, a culture medium, and a method for obtaining the memory lymphocyte population and a use of the same. The memory lymphocyte population contains at least one of the following marker molecules: leukocyte differentiation antigens CD3, CD4, CD8, CD16, CD56, CD62L and CD45RO.
    Type: Application
    Filed: March 23, 2021
    Publication date: August 5, 2021
    Inventors: Ligong Chen, Zhongjie Sun, Hong Zhao, Jianqiang Cai, Junfan Ma, Xiao Guo, Hailong Qi, Qinglei Xue, Shuren Zhang
  • Antibody specific for apolipoprotein and methods of use thereof
    Patent number: 9102717
    Abstract: The present disclosure provides synthetic antibodies specific for an epitope present on an apolipoprotein E polypeptide. The antibodies are useful in various treatment, diagnostic, and monitoring applications, which are also provided.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: August 11, 2015
    Assignee: THE J. DAVID GLADSTONE INSTITUTES
    Inventors: Yadong Huang, Qin Xu, Thu Nga Bien-Ly, Karl H. Weisgraber, Ligong Chen, Clare Peters-Libeu
  • Definition of Two Self-weights for Continuous Random Variable and Their Applications in Basic Statistics
    Publication number: 20140156718
    Abstract: This invention is for how to define two self-weights for continuous random variable based on sampling, how to SAC-normalize a skewed sampling distribution of a continuous random variable without changing the structure of the original measurement scale of the continuous random variable, how to infer representativeness of mathematical mean, and how to take the advantage of the two self-weights to do t-tests in a two-population comparison.
    Type: Application
    Filed: November 30, 2012
    Publication date: June 5, 2014
    Inventor: Ligong Chen
  • Antibody Specific for Apolipoprotein and Methods of Use Thereof
    Publication number: 20130017251
    Abstract: The present disclosure provides synthetic antibodies specific for an epitope present on an apolipoprotein E polypeptide. The antibodies are useful in various treatment, diagnostic, and monitoring applications, which are also provided.
    Type: Application
    Filed: February 25, 2011
    Publication date: January 17, 2013
    Inventors: Yadong Huang, Qin Xu, Thu Nga Bien-Ly, Karl H. Weisgraber, Ligong Chen, Clare Peters-Libeu